This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Perichondritis (pinna)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • perichondritis may be a complicaton of ear piercing
    • "high" piercing, which requires puncture through the cartilage of the upper third of the pinna may cause auricular perichondritis
      • the subperiosteal abscess which may occur with perichondritis often leads to loss of cartilage and to an unsightly deformity known as "cauliflower ear," which has a poor chance of good reconstruction
      • the usual infective agent in auricular perichondritis is Pseudomonas aeruginosa
  • in the early phase of infection, treatment should focus on eradicating Pseudomonas aeruginosa and Staphylococcus aureus
    • antipseudomonal agents such as oral ciprofloxacin or intravenous ticarcillin or carbenicillin are necessary. Ciprofloxacin also has good activity against S aureus
  • keep the patient under close observation
    • failure to respond to treatment requires admission as inpatient to an ear, nose, and throat department.Surgical intervention is required at the earliest sign of an abscess
  • lacerations of the pinna can progress to severe chondritis or perichondritis and so must be fully treated by suturing and antibiotics such as Penicillin plus Flucloxacillin, Co-amoxyclav or Erythromycin

Reference:

  1. BMJ. 2001;322(7291):906-7.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.